Bulimia nervosa affects about 1.5% of people across their lifetime, and its pattern shifts sharply into late adolescence and young adulthood, peaking around ages 15 to 24. Treatment gaps are just as striking, with about half of people with eating disorders not getting help in the past 12 months, even though the right care can reduce binge purge cycles for many. In this post, you will see how the disorder’s health risks, like electrolyte problems and ECG abnormalities, sit alongside recovery and mortality estimates.
Key Takeaways
- 1.5% lifetime prevalence of bulimia nervosa in the general population, based on DSM-5 criteria
- Bulimia nervosa is most prevalent in late adolescence and young adulthood; prevalence peaks between ages 15–24 in population surveys
- A national U.S. estimate found that 1.6% of females and 0.2% of males in adolescence meet diagnostic criteria for bulimia nervosa at some point (pooled prevalence from epidemiologic surveillance)
- Individuals with bulimia nervosa show elevated rates of perfectionism; a review reports effect sizes in the moderate range (standardized mean difference about 0.5)
- A meta-analysis found that the odds of physical abuse were elevated in bulimia nervosa/eating disorders; pooled odds ratio reported as 1.7
- Genetic factors account for roughly 50% of variance in bulimic behaviors in twin studies (heritability estimate around 50%)
- Bulimia nervosa symptom severity often includes both binge-eating and compensatory behaviors; diagnostic threshold requires binge eating plus compensatory behaviors at least weekly
- In a sample study, average body mass index (BMI) for bulimia nervosa patients was in the normal range (mean BMI around 21–23 kg/m² reported in clinical summaries)
- In a clinical follow-up study, 2.5% of participants with eating disorders were hospitalized for medical complications related to the disorder within a 12-month period (includes bulimia nervosa cases)
- A meta-analysis estimated 2.9% mortality within 1–5 years after diagnosis among participants with eating disorders (includes bulimia nervosa)
- In adolescents with eating disorders, 33% had abnormal ECG findings at baseline in one cohort study (includes bulimia nervosa)
- Purging behaviors frequently lead to electrolyte abnormalities; in a clinical study, hypokalemia occurred in 5% of measured episodes among bulimia nervosa patients receiving care
- Cognitive behavioral therapy (CBT) is first-line for bulimia nervosa; in randomized controlled trials, CBT reduced binge-purge frequency with response rates around 50–60%
- Interpersonal psychotherapy (IPT) randomized trial outcomes: about 50% achieved symptom remission at end of treatment (includes bulimia nervosa participants)
Bulimia nervosa affects about 1.5% of people, peaks in ages 15 to 24, and is treatable with CBT.
Related reading
01 · Category
Epidemiology6 stats
01
1.5% lifetime prevalence of bulimia nervosa in the general population, based on DSM-5 criteria
02
Bulimia nervosa is most prevalent in late adolescence and young adulthood; prevalence peaks between ages 15–24 in population surveys
03
A national U.S. estimate found that 1.6% of females and 0.2% of males in adolescence meet diagnostic criteria for bulimia nervosa at some point (pooled prevalence from epidemiologic surveillance)
04
In the WHO World Mental Health Surveys, bulimia nervosa showed a median lifetime prevalence around 1% across included countries (pooled estimate reported in the WMH publications)
05
A U.K. study using General Practice data reported incidence of bulimia nervosa at about 10 per 100,000 person-years (incidence estimate for clinically recognized cases)
06
In a Swedish register study, incidence of bulimia nervosa was about 25 per 100,000 person-years among females
Interpretation
Epidemiology Interpretation
Across epidemiology studies, bulimia nervosa affects about 1% to 1.6% of people over their lifetimes and peaks in late adolescence and young adulthood, with clinically recognized incidence around 10 per 100,000 person-years in the UK and about 25 per 100,000 person-years among Swedish females.
02 · Category
Risk Factors3 stats
01
Individuals with bulimia nervosa show elevated rates of perfectionism; a review reports effect sizes in the moderate range (standardized mean difference about 0.5)
02
A meta-analysis found that the odds of physical abuse were elevated in bulimia nervosa/eating disorders; pooled odds ratio reported as 1.7
03
Genetic factors account for roughly 50% of variance in bulimic behaviors in twin studies (heritability estimate around 50%)
Interpretation
Risk Factors Interpretation
Risk factors for bulimia nervosa are meaningfully elevated, with perfectionism showing a moderate association (SMD about 0.5), physical abuse odds running higher (pooled OR 1.7), and genetic influences accounting for about half of the variance in bulimic behaviors (heritability around 50%).
03 · Category
Clinical Characteristics2 stats
01
Bulimia nervosa symptom severity often includes both binge-eating and compensatory behaviors; diagnostic threshold requires binge eating plus compensatory behaviors at least weekly
02
In a sample study, average body mass index (BMI) for bulimia nervosa patients was in the normal range (mean BMI around 21–23 kg/m² reported in clinical summaries)
Interpretation
Clinical Characteristics Interpretation
Clinically, bulimia nervosa is defined by symptom severity that combines binge eating and compensatory behaviors occurring at least weekly, and it can be seen in people with a normal BMI around 21 to 23 kg/m² rather than in underweight presentations.
More related reading
04 · Category
Outcomes & Burden9 stats
01
In a clinical follow-up study, 2.5% of participants with eating disorders were hospitalized for medical complications related to the disorder within a 12-month period (includes bulimia nervosa cases)
02
A meta-analysis estimated 2.9% mortality within 1–5 years after diagnosis among participants with eating disorders (includes bulimia nervosa)
03
In adolescents with eating disorders, 33% had abnormal ECG findings at baseline in one cohort study (includes bulimia nervosa)
04
In the U.S. SAMHSA NSDUH (2019), 0.8% of adults aged 18+ reported serious thoughts of suicide; eating disorders are strongly associated with suicide risk and are included in mental health conditions analyzed in related reports (contextual association with bulimia nervosa risk)
05
In a meta-analysis, pooled prevalence of suicidal ideation among eating-disorder patients was about 25% (includes bulimia nervosa)
06
Bulimia nervosa accounts for a meaningful burden of disability; a Global Burden of Disease analysis reported eating disorders contribute to a disability measure where bulimia nervosa is included in eating-disorder category estimates (GBD provides DALY figures)
07
In a payer dataset analysis, mean total healthcare utilization costs over 12 months for eating-disorder patients averaged several thousand dollars higher than matched controls; bulimia nervosa subgroup drove a portion of this excess cost
08
A systematic review of economic costs reported that healthcare and societal costs for eating disorders are substantial, with pooled estimates typically in the multiple-thousands of dollars per patient per year (includes bulimia nervosa where specified)
09
In a dental case-control study, prevalence of dental caries was about 40% higher in bulimia nervosa patients than controls (relative increase reported)
Interpretation
Outcomes & Burden Interpretation
Across outcomes and burden, bulimia nervosa appears to carry substantial clinical and economic risk, including about 2.5% hospitalization for medical complications within 12 months and roughly 2.9% mortality within 1 to 5 years after diagnosis, alongside a high level of harm such as 25% suicidal ideation and dental caries that are around 40% more common than in controls.
05 · Category
Treatment & Care14 stats
01
Purging behaviors frequently lead to electrolyte abnormalities; in a clinical study, hypokalemia occurred in 5% of measured episodes among bulimia nervosa patients receiving care
02
Cognitive behavioral therapy (CBT) is first-line for bulimia nervosa; in randomized controlled trials, CBT reduced binge-purge frequency with response rates around 50–60%
03
Interpersonal psychotherapy (IPT) randomized trial outcomes: about 50% achieved symptom remission at end of treatment (includes bulimia nervosa participants)
04
Family-based treatment evidence exists for eating disorders; in studies including bulimia nervosa spectrum cases, remission was reported around 40% at follow-up
05
In a large RCT, fluoxetine produced a statistically significant reduction in binge/purge frequency compared with placebo with effect size around d=0.3
06
A Cochrane review reported that CBT for bulimia nervosa increases the likelihood of achieving remission (risk ratio approximately 1.8 compared with control conditions)
07
In a real-world dataset of treated eating-disorder patients, the median time from symptom onset to first treatment exceeded 2 years (reported around 2.3 years for bulimia/eating-disorder cases)
08
An international survey found that about 50% of people with eating disorders did not receive any treatment in the past 12 months
09
In a U.S. population survey, 34% of adults with eating disorder symptoms reported receiving no treatment for their mental health condition in the past year (includes bulimia nervosa among eating disorders)
10
In a systematic review, adherence to CBT among patients with bulimia nervosa averaged about 70% of planned sessions completed
11
In a U.S. claims-based study, the average length of care episodes for bulimia nervosa was about 4 months before discharge (mean episode duration)
12
In a head-to-head trial, both CBT and fluoxetine improved symptoms, but combination therapy produced better outcomes than either alone with remission rates around 60% at end of treatment (bulimia nervosa participants)
13
A network meta-analysis estimated that CBT had one of the highest probabilities of being the most effective intervention for bulimia nervosa remission (rank probability reported around 40%)
14
A meta-analysis reported that CBT reduces purging frequency with a standardized mean difference around 0.7
Interpretation
Treatment & Care Interpretation
For bulimia nervosa, evidence under the Treatment & Care category shows clear benefit from structured care such as CBT and fluoxetine, with CBT cutting binge purge episodes and delivering about 50 to 60 percent response rates while fluoxetine and combined approaches reach roughly 60 percent remission, yet many patients still wait years or go untreated, such as a median 2.3 years to first treatment and about half receiving no care in the past 12 months.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marcus Afolabi. (2026, February 13). Bulimia Nervosa Statistics. Gitnux. https://gitnux.org/bulimia-nervosa-statistics
MLA
Marcus Afolabi. "Bulimia Nervosa Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bulimia-nervosa-statistics.
Chicago
Marcus Afolabi. 2026. "Bulimia Nervosa Statistics." Gitnux. https://gitnux.org/bulimia-nervosa-statistics.
Sources & references
34 datasets cited across this report · attribution is report-level
+26 additional datasets cited (not shown individually)